Royal Bank of Canada’s Clearmind Medicine CMND Stock Holding History

Royal Bank of Canada’s Portfolio CMND Stock Details CMND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1K	Buy	287 +286	+28,600%	+$1.63K	﹤0.01%	7215
2026 Q1	$0	Hold	1	–	–	﹤0.01%	7187
2025 Q4	$0	Hold	1	–	–	﹤0.01%	7221
2025 Q3	$1K	Hold	1	–	–	﹤0.01%	6961
2025 Q2	$1K	Hold	1	–	–	﹤0.01%	6862
2025 Q1	$1K	Hold	1	–	–	﹤0.01%	6640
2024 Q4	$1K	Hold	1	–	–	﹤0.01%	6761
2024 Q3	$1K	Hold	1	–	–	﹤0.01%	6691
2024 Q2	$1K	Hold	1	–	–	﹤0.01%	6798
2024 Q1	$1K	Buy	+1	New	+$612	﹤0.01%	6771

Other funds holding CMND

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Royal Bank of Canada's CMND Position: Q2 2026 in Review

Royal Bank of Canada increased its Clearmind Medicine (CMND) stake by 28,600% in Q2 2026, buying an estimated $1.63K and bringing the position to 287 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #7215.

Royal Bank of Canada first reported a position in CMND in Q1 2024 and has held it in 10 quarters since. 6 funds tracked by Wall St. Rank hold CMND as of Q2 2026.

Royal Bank of Canada held 287 shares of Clearmind Medicine worth $1K as of Q2 2026.
Royal Bank of Canada bought 286 Clearmind Medicine shares in Q2 2026, an estimated $1.63K.
Clearmind Medicine made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #7215 holding.
Royal Bank of Canada first reported a position in Clearmind Medicine in Q1 2024 and has held it in 10 quarters since.
6 funds tracked by Wall St. Rank held Clearmind Medicine as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.